Radiographic PFS in Metastatic CRPC More Than Doubles With Novel Combination

(MedPage Today) -- SAN FRANCISCO -- Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) more than doubled with the addition of an investigational targeted therapy to standard treatment, a randomized...